Results 201 to 210 of about 131,760 (358)

Nutritional priorities to support GLP‐1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society

open access: yesObesity, Volume 33, Issue 8, Page 1475-1503, August 2025.
Abstract Background Glucagon‐like peptide 1 receptor agonists and combination medications (hereafter collectively referred to as GLP‐1s) are shifting the treatment landscape for obesity. However, real‐world challenges and limited clinician and public knowledge on nutritional and lifestyle interventions can limit GLP‐1 efficacy, equitable results, and ...
Dariush Mozaffarian   +17 more
wiley   +1 more source

Effect of ACTH Infusion test on cortisol-4-C14 binding to plasma proteins [PDF]

open access: yes, 1967
Hochheuser, W.   +3 more
core  

Hypersscretion of ACTH growth hormone and prolactin in a patient with pituitary adenoma [PDF]

open access: yes, 1978
Fink, R.   +3 more
core   +1 more source

Central effects of ghrelin on the adrenal cortex: a morphological and hormonal study

open access: bronze, 2010
Verica Milošević   +6 more
openalex   +2 more sources

Wilms Tumor in Children With AMER1/WTX Germline Pathogenic Variants: A Multicenter Case Series

open access: yesPediatric Blood &Cancer, Volume 72, Issue 8, August 2025.
ABSTRACT Background 10–15% of children with Wilms tumor (WT) have predisposing genetic syndromes. Somatic mutations are frequently identified; however, germline pathogenic variants in AMER1 are much less prevalent and are associated with osteopathia striata with cranial sclerosis (OSCS).
Insiyah Campwala   +9 more
wiley   +1 more source

Role of TRPV1 in neuroendocrine regulation: a potential target against obesity? [PDF]

open access: yesFront Immunol
Wang J   +6 more
europepmc   +1 more source

Diagnostic pathology of equine intracranial neoplasms

open access: yes
Equine Veterinary Education, Volume 37, Issue 9, Page 456-460, September 2025.
H. G. Miller, A. Suarez‐Bonnet
wiley   +1 more source

Advancing antihypertensive drug development

open access: yesBritish Journal of Pharmacology, Volume 182, Issue 15, Page 3389-3410, August 2025.
Hypertension affects more than a billion individuals worldwide and remains a major cause of cardiovascular morbidity and mortality. Despite advances in therapies, optimal blood pressure control remains elusive for many patients because of treatment resistance, adverse effects, and adherence challenges.
Fay Pu   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy